Acetylcysteine Teva effervescent tablets 600 mg tube 10 pcs.

• active ingredient: acetylcysteine;
• 1 effervescent tablet contains: acetylcysteine ​​600 mg;
• excipients: anhydrous citric acid, sodium bicarbonate, adipic acid, povidone 25, micronized adipic acid, aspartame (E 951), spray-dried lemon flavor, 213°841 (flavoring agent, maltodextrin, sucrose, gum arabic (E 414), glycerol triacetate (triacetin) (E 1518), alpha-tocopherol (E 307)).

Hypersensitivity to acetylcysteine ​​or to any of the excipients.

Gastric and duodenal ulcer in the acute stage, hemoptysis, pulmonary hemorrhage.

Due to the high content of the active substance, the drug should not be used in children under 14 years of age.

The effervescent tablet should be dissolved in a glass of drinking water and the entire contents of the glass should be drunk. The medicine should be taken without delay, immediately after preparing the solution.

Adults and children over 14 years of age – 1 effervescent tablet once a day (equivalent to 600 mg of acetylcysteine ​​per day).

The duration of the course of treatment is determined by the doctor individually, depending on the nature of the disease (acute or chronic). The drug should not be used for more than 4-5 days without consulting a doctor.

Patients with bronchial asthma should be closely monitored during treatment due to the possible development of bronchospasm. In the event of bronchospasm, treatment with acetylcysteine ​​should be discontinued immediately.

It is recommended to use the drug with caution in patients with a history of gastric and duodenal ulcers, especially in case of concomitant use of other medications that irritate the gastric mucosa.

Acetylcysteine ​​should be administered with caution to patients with liver or kidney disease to avoid the accumulation of nitrogenous substances in the body.

Acetylcysteine ​​affects histamine metabolism, so caution should be exercised when used in patients with histamine intolerance. Long-term therapy should not be prescribed to such patients, as this may lead to symptoms of intolerance (headache, vasomotor rhinitis, itching).

Use during pregnancy or breastfeeding

The drug should be used during pregnancy or breastfeeding only after careful assessment of the benefit/risk ratio.

Children

Use for children over 14 years of age.

Ability to influence reaction speed when driving vehicles or other mechanisms

There is no evidence that acetylcysteine ​​affects the ability to drive and use machines.

There are no data on cases of overdose with oral administration of acetylcysteine.

Immune system disorders: infrequently – hypersensitivity; very rarely – anaphylactic shock, anaphylactic/anaphylactoid reactions.

Blood and lymphatic system disorders: frequency unknown – anemia.

From the nervous system: infrequently – headache.

From the side of the organs of hearing and labyrinth: infrequently – tinnitus.

Cardiac: infrequently – tachycardia.

Vascular disorders: very rarely – hemorrhages.

From the respiratory system: rarely – bronchospasm, dyspnea; frequency unknown – rhinorrhea.

Gastrointestinal: infrequently – vomiting, diarrhea, stomatitis, abdominal pain, nausea; rarely – dyspepsia; frequency unknown – bad breath.

Skin and subcutaneous tissue disorders: infrequently – urticaria, rash, angioedema, itching; frequency unknown – eczema.

Interaction studies were conducted only with adults.

The use of antitussives together with acetylcysteine ​​may increase sputum congestion due to suppression of the cough reflex, therefore indications for such combined treatment should be established with particular caution.

Activated charcoal reduces the effectiveness of acetylcysteine.

Store at a temperature not exceeding 25°C in a tightly closed tube to protect from moisture. Keep out of the reach of children.

Shelf life 2 years. Shelf life after first opening the tube is 12 months.